An increased reporting of shigellosis cases, mainly caused by Shigella sonnei, among travellers returning from Cabo Verde has been ongoing in the European Union/European Economic Area (EU/EEA), the United Kingdom (UK), and the United States (US) since September 2022. This outbreak evolved rapidly during November and December 2022.
This evidence brief summarises key issues and priorities for action in Europe and Central Asia on PrEP. It is largely based on data collected between February and August 2022.
This issue of the CDTR covers the period 27 November – 3 December 2022 and includes updates on COVID-19, Ebola, diphtheria, respiratory syncytial virus, seasonal influenza, monkeypox, mass gathering monitoring at the FIFA World Cup 2022 Qatar, Chikungunya, dengue, Shigella sonnei, poliomyelitis, meningitis, cholera.
You may already know about PrEP - the pill one takes to reduce the risk of acquiring HIV. But did you know there is also PEP - the post-exposure prophylaxis - that is used after one may have been exposed to the HIV virus.
This report is the latest in a series published jointly by the European Centre for Disease Prevention and Control (ECDC) and the WHO Regional Office for Europe that has been reporting data on HIV and AIDS in the WHO European Region and in the European Union and European Economic Area (EU/EEA) since 2007.